2nd Annual Bio/Pharmaceutical Legal Congress

With over 14 industry perspectives and 4 key government speakers, CBI’s 2nd Annual Life Sciences Legal Congress is your September CLE Event focused on the major areas that General and Corporate Counsel face on a daily basis. Share best practices and learn from experts about leading compliance and enforcement issues, intellectual property due diligence and corporate transaction approaches as companies are on the brink of adapting within a changing political/legal landscape.

With a combination of workshops, didactic presentations and panel discussions, this congress provides a unique forum for benchmarking and networking on the following topics:

1. The Sunshine Act and the proliferation of global transparency developments
2. Litigation involving price reporting
3. Enforcement priorities from government officials
4. Patent law developments, including reverse payment settlements and skinny label approval
5. Emerging trends within M&A and other strategic transactions
6. Implications of off-label communications, the Park Doctrine and FCPA

PLUS! Don’t miss the pre-conference General Counsel Summit and Government Pricing Summit!